AEON Biopharma News

AEON Biopharma | EFFECT: Others

Aug 22 06:05 ET

AEON Biopharma | 424B5: Prospectus

Aug 21 16:31 ET

AEON Biopharma | S-3: Registration statement for specified transactions by certain issuers

Aug 15 13:26 ET

AEON Biopharma | 424B3: Prospectus

Aug 12 16:21 ET

AEON Biopharma | 10-K/A: Annual report (Amendment)

Aug 12 16:21 ET

AEON Biopharma | 8-K: AEON Biopharma Reports Second Quarter 2024 Financial Results and Provides Corporate Update

Aug 12 16:13 ET

AEON Biopharma | 10-Q: Quarterly report

Aug 12 16:06 ET

AEON Biopharma | 8-K: Current report

Aug 6 16:11 ET

AEON Biopharma | EFFECT: Others

Aug 6 06:09 ET

AEON Biopharma | 424B3: Prospectus

Aug 5 16:38 ET

AEON Biopharma | 144: Notice of proposed sale of securities pursuant to Rule 144

Jul 29 16:15 ET

AEON Biopharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

Jul 23 16:45 ET

AEON Biopharma | UPLOAD: Others

Jul 16 13:35 ET

AEON Biopharma | CORRESP: CORRESP

Jul 9 13:35 ET

AEON Biopharma | 8-K: Current report

Jul 9 08:10 ET

AEON Biopharma | UPLOAD: Others

Jun 27 13:35 ET

AEON Biopharma | 8-K: Current report

Jun 14 16:19 ET

AEON Biopharma | S-1/A: General form for registration of securities under the Securities Act of 1933 (Amendment)

May 31 16:09 ET

AEON Biopharma | 3: Initial statement of beneficial ownership of securities-Officer Sy Jennifer

May 24 20:07 ET

AEON Biopharma | 8-K: Current report

May 16 16:33 ET